These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7835820)

  • 1. [Accelerated breakdown of membrane phospholipids in schizophrenia--implications for the hypofrontality hypothesis].
    Gattaz WF; Brunner J; Schmitt A; Maras A
    Fortschr Neurol Psychiatr; 1994 Dec; 62(12):489-96. PubMed ID: 7835820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebral injection of phospholipase A2 inhibits dopamine-mediated behavior in rats: possible implications for schizophrenia.
    Brunner J; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 1995; 246(1):13-6. PubMed ID: 8773214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase A2 and the hypofrontality hypothesis of schizophrenia.
    Gattaz WF; Brunner J
    Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):109-13. PubMed ID: 8888132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased platelet phospholipase A2 activity in schizophrenia.
    Gattaz WF; Schmitt A; Maras A
    Schizophr Res; 1995 Jul; 16(1):1-6. PubMed ID: 7547640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possible involvement of phospholipase A2 in the pathogenesis of schizophrenia].
    Gattaz WF; Nevalainen TJ; Kinnunen PK
    Fortschr Neurol Psychiatr; 1990 Apr; 58(4):148-53. PubMed ID: 2354835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy.
    Gattaz WF; Köllisch M; Thuren T; Virtanen JA; Kinnunen PK
    Biol Psychiatry; 1987 Apr; 22(4):421-6. PubMed ID: 3567258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relevance of metabolism of membrane phospholipids for Alzheimer dementia].
    Gattaz WF; Levy R; Cairns NJ; Förstl H; Braus DF; Maras A
    Fortschr Neurol Psychiatr; 1996 Jan; 64(1):8-12. PubMed ID: 8850090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum phospholipase A2 activity in schizophrenia: a replication study.
    Gattaz WF; Hübner CV; Nevalainen TJ; Thuren T; Kinnunen PK
    Biol Psychiatry; 1990 Sep; 28(6):495-501. PubMed ID: 2223919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of brain membranes in schizophrenia: impact of phospholipase A(2).
    Schaeffer EL; Gattaz WF; Eckert GP
    Curr Top Med Chem; 2012; 12(21):2314-23. PubMed ID: 23279172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia.
    Schmitt A; Maras A; Petroianu G; Braus DF; Scheuer L; Gattaz WF
    J Neural Transm (Vienna); 2001; 108(8-9):1081-91. PubMed ID: 11716143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.
    Ross BM; Hudson C; Erlich J; Warsh JJ; Kish SJ
    Arch Gen Psychiatry; 1997 May; 54(5):487-94. PubMed ID: 9152103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.
    Ross BM; Turenne S; Moszczynska A; Warsh JJ; Kish SJ
    Brain Res; 1999 Mar; 821(2):407-13. PubMed ID: 10064828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebroventricular injection of phospholipase A2 inhibits apomorphine-induced locomotion in rats.
    Brunner J; Gattaz WF
    Psychiatry Res; 1995 Sep; 58(2):165-9. PubMed ID: 8570769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia.
    Barbosa NR; Junqueira RM; Vallada HP; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):340-3. PubMed ID: 17629734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased phospholipase A2 activity in schizophrenia with absent response to niacin.
    Tavares H; Yacubian J; Talib LL; Barbosa NR; Gattaz WF
    Schizophr Res; 2003 May; 61(1):1-6. PubMed ID: 12648730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antipsychotics and phospholipid metabolism in schizophrenia].
    Schmitt A; Maras A; Braus DF; Petroianu G; Jatzko A; Gattaz WF
    Fortschr Neurol Psychiatr; 2001 Nov; 69(11):503-9. PubMed ID: 11704897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontal lobe metabolism and cerebral morphology in schizophrenia: 31P MRS and MRI studies.
    Keshavan MS; Sanders RD; Pettegrew JW; Dombrowsky SM; Panchalingam KS
    Schizophr Res; 1993 Oct; 10(3):241-6. PubMed ID: 8260442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicated chronic schizophrenic patients do not demonstrate left turning asymmetry.
    Levine J; Martine T; Feraro R; Kimhi R; Bracha HS
    Neuropsychobiology; 1997; 36(1):22-4. PubMed ID: 9211440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study.
    Stanley JA; Williamson PC; Drost DJ; Carr TJ; Rylett RJ; Morrison-Stewart S; Thompson RT
    Schizophr Res; 1994 Oct; 13(3):209-15. PubMed ID: 7841133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase A2 activity in serum of neuroleptic-naive psychiatric inpatients.
    Albers M; Meurer H; Märki F; Klotz J
    Pharmacopsychiatry; 1993 May; 26(3):94-8. PubMed ID: 8415900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.